213 related articles for article (PubMed ID: 12893186)
1. Enhanced p53 gene transfer to human ovarian cancer cells using the cationic nonviral vector, DDC.
Kim CK; Choi EJ; Choi SH; Park JS; Haider KH; Ahn WS
Gynecol Oncol; 2003 Aug; 90(2):265-72. PubMed ID: 12893186
[TBL] [Abstract][Full Text] [Related]
2. Nonviral vector for efficient gene transfer to human ovarian adenocarcinoma cells.
Kim CK; Haider KH; Choi SH; Choi EJ; Ahn WS; Kim YB
Gynecol Oncol; 2002 Jan; 84(1):85-93. PubMed ID: 11748982
[TBL] [Abstract][Full Text] [Related]
3. Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells.
Choi SH; Jin SE; Lee MK; Lim SJ; Park JS; Kim BG; Ahn WS; Kim CK
Eur J Pharm Biopharm; 2008 Mar; 68(3):545-54. PubMed ID: 17881199
[TBL] [Abstract][Full Text] [Related]
4. Novel luminescent silica nanoparticles (LSN): p53 gene delivery system in breast cancer in vitro and in vivo.
Rejeeth C; Salem A
J Pharm Pharmacol; 2016 Mar; 68(3):305-15. PubMed ID: 27085860
[TBL] [Abstract][Full Text] [Related]
5. In vivo expression and antitumor activity of p53 gene transfer with naked plasmid DNA in an ovarian cancer xenograft model in nude mice.
Collinet P; Vereecque R; Sabban F; Vinatier D; Leblanc E; Narducci F; Querleu D; Quesnel B
J Obstet Gynaecol Res; 2006 Oct; 32(5):449-53. PubMed ID: 16984510
[TBL] [Abstract][Full Text] [Related]
6. A cationic cholesterol based nanocarrier for the delivery of p53-EGFP-C3 plasmid to cancer cells.
Misra SK; Naz S; Kondaiah P; Bhattacharya S
Biomaterials; 2014 Jan; 35(4):1334-46. PubMed ID: 24211075
[TBL] [Abstract][Full Text] [Related]
7. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
[TBL] [Abstract][Full Text] [Related]
8. Structural characterization of a new lipid/DNA complex showing a selective transfection efficiency in ovarian cancer cells.
Caracciolo G; Pozzi D; Caminiti R; Congiu Castellano A
Eur Phys J E Soft Matter; 2003 Apr; 10(4):331-6. PubMed ID: 15015096
[TBL] [Abstract][Full Text] [Related]
9. Growth suppression of human ovarian carcinoma OV-MZ-2a and OV-MZ-32 cells mediated by gene transfer of wild-type p53 enhanced by chemotherapy in vitro.
Wu Q; Kreienberg R; Runnebaum IB
J Cancer Res Clin Oncol; 2000 Mar; 126(3):139-44. PubMed ID: 10741907
[TBL] [Abstract][Full Text] [Related]
10. Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells.
Kigawa J; Sato S; Shimada M; Kanamori Y; Itamochi H; Terakawa N
Gynecol Oncol; 2002 Feb; 84(2):210-5. PubMed ID: 11812076
[TBL] [Abstract][Full Text] [Related]
11. Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.
Yang F; Gou M; Deng H; Yi T; Zhong Q; Wei Y; Zhao X
Oncol Rep; 2012 Aug; 28(2):668-76. PubMed ID: 22684947
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer.
Modesitt SC; Ramirez P; Zu Z; Bodurka-Bevers D; Gershenson D; Wolf JK
Clin Cancer Res; 2001 Jun; 7(6):1765-72. PubMed ID: 11410518
[TBL] [Abstract][Full Text] [Related]
13. Effect of DNA/liposome mixing ratio on the physicochemical characteristics, cellular uptake and intracellular trafficking of plasmid DNA/cationic liposome complexes and subsequent gene expression.
Sakurai F; Inoue R; Nishino Y; Okuda A; Matsumoto O; Taga T; Yamashita F; Takakura Y; Hashida M
J Control Release; 2000 May; 66(2-3):255-69. PubMed ID: 10742585
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of plasmid DNA and antisense oligodeoxyribonucleotide into human carcinoma cells by cationic liposomes.
Weecharangsan W; Opanasopit P; Yingyongnarongkul BE; Kewsuwan P; Lee RJ
Curr Pharm Biotechnol; 2014; 15(9):790-9. PubMed ID: 25307014
[TBL] [Abstract][Full Text] [Related]
15. [Effects of small interfering RNA specific to stably transfected HMGA1 gene on biological characters of ovarian carcinoma cells].
Liu YL; Zheng JH
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):51-5. PubMed ID: 20367927
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal gene delivery mediated by a novel cationic liposome in a peritoneal disseminated ovarian cancer model.
Lee MJ; Cho SS; You JR; Lee Y; Kang BD; Choi JS; Park JW; Suh YL; Kim JA; Kim DK; Park JS
Gene Ther; 2002 Jul; 9(13):859-66. PubMed ID: 12080380
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
18. Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant.
Peng XC; Yang L; Yang LP; Mao YQ; Yang HS; Liu JY; Zhang DM; Chen LJ; Wei YQ
J Exp Clin Cancer Res; 2008 Sep; 27(1):46. PubMed ID: 18816410
[TBL] [Abstract][Full Text] [Related]
19. Complexes containing cationic and anionic pH-sensitive liposomes: comparative study of factors influencing plasmid DNA gene delivery to tumors.
Chen Y; Sun J; Lu Y; Tao C; Huang J; Zhang H; Yu Y; Zou H; Gao J; Zhong Y
Int J Nanomedicine; 2013; 8():1573-93. PubMed ID: 23637529
[TBL] [Abstract][Full Text] [Related]
20. Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors.
Lu D; Benjamin R; Kim M; Conry RM; Curiel DT
Cancer Gene Ther; 1994 Dec; 1(4):245-52. PubMed ID: 7627814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
